Campath‐1h, a humanized monoclonal antibody, in refractory rheumatoid arthritis

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1988 • 19,632 citations

Humanised monoclonal antibody therapy for rheumatoid arthritis

1992 • 316 citations

Analysis of improvement in individual rheumatoid arthritis patients treated with disease‐modifying antirheumatic drugs, based on the findings in patients treated with placebo

1990 • 289 citations

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy

1993 • 205 citations

Use of a chimeric monoclonal anti‐CD4 antibody in patients with refractory rheumatoid arthritis

1993 • 120 citations

Treatment of refractory rheumatoid arthritis with a chimeric ANTI‐CD4 monoclonal antibody

1994 • 118 citations

Effects of administration of an anti‐cd5 plus immunoconjugate in rheumatoid arthritis. results of two phase ii studies

1993 • 79 citations

Synovial tissue response to treatment with campath‐1h

1995 • 54 citations

Chimeric CD7 monoclonal antibody therapy in rheumatoid arthritis.

1992 • 46 citations

Humanized monoclonal antibody treatment in rheumatoid arthritis.

1991 • 22 citations